Arcturus Therapeutics Holdings Inc. (ARCT)

8.93
NASDAQ : Health Technology
Prev Close 9.62
Day Low/High 8.72 / 9.79
52 Wk Low/High 4.11 / 15.50
Avg Volume 77.40K
Exchange NASDAQ
Shares Outstanding 15.13M
Market Cap 145.51M
EPS -2.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Arcturus Therapeutics To Report Corporate Overview And Financial Results On November 7th

Arcturus Therapeutics To Report Corporate Overview And Financial Results On November 7th

SAN DIEGO, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases, today announced that it will...

Arcturus Therapeutics To Present At Three Upcoming Investor Conferences

Arcturus Therapeutics To Present At Three Upcoming Investor Conferences

SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ESQ, EYE, HMI, MG, PAM, ROX, SFIX Downgrades: BNED, DL, JOBS, LZB, NRT Initiations: ARCT, ICLK, NESR, RFL Read on to get TheStreet Quant Ratings' detailed report:

Arcturus Therapeutics Issues Statement

Arcturus Therapeutics Issues Statement

CureVac And Arcturus Therapeutics Announce Broad Strategic Collaboration To Advance Next Generation Of Lipid-Mediated MRNA Therapeutics

CureVac And Arcturus Therapeutics Announce Broad Strategic Collaboration To Advance Next Generation Of Lipid-Mediated MRNA Therapeutics

CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of pioneering mRNA therapeutics, and Arcturus Therapeutics Ltd.

Net Lease Sector Endures More Consolidation

Net Lease Sector Endures More Consolidation

The proposed deal with CapLease will provide one of the few missing components for ARCP's growing net lease brand: management.

Clock Ticking for Empire State Building IPO

Clock Ticking for Empire State Building IPO

The portfolio consists of 12 total office properties encompassing approximately 7.7 million rentable square feet of office space, most located in the Manhattan area.

Realty Income Cements Dividend With ARCT Merger

Realty Income Cements Dividend With ARCT Merger

As a result, one of the best REITs around just got better.

Luxor Capital Loves REITs

Luxor Capital Loves REITs

The hedge fund is buying up shares of American Realty Capital Trust.

Sandell Commends Improved ARCT-Realty Income Merger Terms

Sandell Commends Improved ARCT-Realty Income Merger Terms

In response to American Realty Capital Trust (NASDAQ: ARCT) and Realty Income Corporation amending the terms of their merger agreement, Sandell Asset Management’s Chief Executive Officer Thomas E.

Realty Income And American Realty Capital Trust Announce Amended Merger Agreement

Realty Income And American Realty Capital Trust Announce Amended Merger Agreement

Realty Income Corporation, the Monthly Dividend Company®, (NYSE: O) (“Realty Income”) and American Realty Capital Trust, Inc.

Free-Standing REITs: Separating the Best from the Rest

Free-Standing REITs: Separating the Best from the Rest

Sleep well at night investing in these free-standing REITs.

This Small Cap REIT Is a Diamond in the Rough

This Small Cap REIT Is a Diamond in the Rough

Management has knowledge and experience to guide for tough times.

Law Office Of Brodsky & Smith, LLC Announces Investigation Of American Realty Capital Trust, Inc.

Law Office Of Brodsky & Smith, LLC Announces Investigation Of American Realty Capital Trust, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of American Realty Capital Trust, Inc.

Cramer's 'Mad Money' Recap: A Rally Based on Facts

Cramer's 'Mad Money' Recap: A Rally Based on Facts

Cramer says he's no longer afraid of the future.

Finkelstein Thompson LLP Announces Investigation Of American Realty Capital Trust, Inc.

Finkelstein Thompson LLP Announces Investigation Of American Realty Capital Trust, Inc.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of American Realty Capital Trust, Inc.

The Law Firm Of WeissLaw LLP Investigates American Realty Capital Trust, Inc.

The Law Firm Of WeissLaw LLP Investigates American Realty Capital Trust, Inc.

WeissLaw LLP, a national class action and shareholder rights firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of ...

TheStreet Quant Rating: D (Sell)